MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV)

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

TAVAKOLI AHMAD; KARBALAIE NIYA MOHAMMAD HADI; KESHAVARZ MOHSEN; SAFARNEZHAD TAMESHKEL FAHIMEH; MONAVARI SEYED HAMIDREZA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Medical Microbiology Year:2017 | Volume:11 | Issue:1 Page(s): 1-8

Download Full-Text

Persian Verion

View:

2,789

Download:

Cites:

Information Journal Paper

Title

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV)

Author(s)

Keywords

MIDDLE EAST RESPIRATORY SYNDROMEQ2

MERS-COVQ2

ACUTE RESPIRATORY ILLNESSQ2

SARSQ2

Abstract

The MIDDLE EAST RESPIRATORY SYNDROME coronavirus (MERS-CoV) as a causative agent of severe lower respiratory tract infection in humans, considered as a global threat, especially against to Persian Gulf countries. Since its discovery in 2012, MERS-COV has spread 27 countries affecting about 1800 people and caused more than 600 deaths in worldwide. In comparison to SARS (severe acute respiratory syndrome), MERS-COV appears to have a higher mortality rate (40% versus 10%) and is particularly more severe in patients with underlying medical conditions. Until now, the most MERS-COV cases (more than 85 percent) have had a history of travel or residence in the Middle East countries. A possible intermediate host for MERS-COVis camel. Clinical manifestations of MERS range from mild or asymptomatic disease to acute respiratory syndrome and multi-organ failure resulting in death, mostly in individuals with preexisting medical co-morbidities. There is no specific antiviral treatment for MERS and infection prevention and control practices are necessary to prevent spread of MERS-COV in health care facilities. In present study, we have briefly outlined the recent information about the epidemiology, clinical features, diagnosis, treatment and prevention of MERS-COV.

Cites

No record.

References

Cite

APA: Copy

TAVAKOLI, AHMAD, KARBALAIE NIYA, MOHAMMAD HADI, KESHAVARZ, MOHSEN, SAFARNEZHAD TAMESHKEL, FAHIMEH, & MONAVARI, SEYED HAMIDREZA. (2017). MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV). IRANIAN JOURNAL OF MEDICAL MICROBIOLOGY, 11(1), 1-8. SID. https://sid.ir/paper/132715/en

Vancouver: Copy

TAVAKOLI AHMAD, KARBALAIE NIYA MOHAMMAD HADI, KESHAVARZ MOHSEN, SAFARNEZHAD TAMESHKEL FAHIMEH, MONAVARI SEYED HAMIDREZA. MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV). IRANIAN JOURNAL OF MEDICAL MICROBIOLOGY[Internet]. 2017;11(1):1-8. Available from: https://sid.ir/paper/132715/en

IEEE: Copy

AHMAD TAVAKOLI, MOHAMMAD HADI KARBALAIE NIYA, MOHSEN KESHAVARZ, FAHIMEH SAFARNEZHAD TAMESHKEL, and SEYED HAMIDREZA MONAVARI, “MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV),” IRANIAN JOURNAL OF MEDICAL MICROBIOLOGY, vol. 11, no. 1, pp. 1–8, 2017, [Online]. Available: https://sid.ir/paper/132715/en

Related Journal Papers